← Back to Feed

/GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

November 10, 2026 at 12:44 AM

The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.

The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.

Read the full article on CBS News

Read Full Article →

Home News Feed BLERBZ100 About

© 2026 Blerbz. All rights reserved. | Privacy | Terms

glp 1s Must now Include Warning for Potential Increased | Blerbz